UNIVERSITY COLLEGE LONDON
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
EVERREST Developing a Therapy for Fetal Growth Restriction
Completed
- Conditions
- Fetal Growth Retardation
- First Posted Date
- 2014-03-27
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- University College, London
- Target Recruit Count
- 142
- Registration Number
- NCT02097667
- Locations
- π©πͺ
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
πΈπͺLund University Hospital and University Hospital MalmΓΆ, Malmo, Sweden
πͺπΈMaternal-Fetal Unit Hospital Clinic de Barcelona, Barcelona, Spain
Tooth Loss in Periodontitis Patients
- Conditions
- Periodontitis
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2017-09-27
- Lead Sponsor
- University College, London
- Target Recruit Count
- 200
- Registration Number
- NCT02091258
- Locations
- π¬π§
Ravenscourt Dental Practice, London, United Kingdom
π¬π§The Dentist, Bishop's Stortford, Herts, United Kingdom
Physical Activity and Self-Efficacy After Pulmonary Rehabilitation
- Conditions
- Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- University College, London
- Target Recruit Count
- 30
- Registration Number
- NCT02086383
- Locations
- π¬π§
St. Thomas' Hospital, City of Westminster, London, United Kingdom
Metabolic Response to Playing Video Games: Two Arm Trial
Not Applicable
- Conditions
- Appetite and General Nutritional DisordersSedentary Lifestyle
- Interventions
- Behavioral: Competitive video gameBehavioral: Little Big Planet
- First Posted Date
- 2014-03-03
- Last Posted Date
- 2014-03-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 72
- Registration Number
- NCT02075827
- Locations
- π¬π§
UCL Institute of Child Health, London, United Kingdom
Autologous Stem Cells in Achilles Tendinopathy
Phase 2
- Conditions
- Achilles Tendinitis, Right LegAchilles DegenerationTendinopathyAchilles TendinitisAchilles Tendon ThickeningAchilles Tendinitis, Left Leg
- Interventions
- Biological: Autologous Mesenchymal Stem Cells
- First Posted Date
- 2014-02-17
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University College, London
- Target Recruit Count
- 10
- Registration Number
- NCT02064062
- Locations
- π¬π§
Royal National Orthopaedic Hospital, London, United Kingdom
Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease
- Conditions
- StrokeSubarachnoid HaemorrhageTransient Ischemic AttackPeripheral Arterial DiseaseStable Angina PectorisAbdominal Aortic AneurysmMyocardial InfarctionIschemic StrokeVenous ThrombosisUnstable Angina
- First Posted Date
- 2014-02-13
- Last Posted Date
- 2015-04-21
- Lead Sponsor
- University College, London
- Target Recruit Count
- 200000
- Registration Number
- NCT02062021
- Locations
- π¬π§
University College London, London, United Kingdom
Brain Mechanisms Underlying Reading Improvement in Central Alexia
Not Applicable
Completed
- Conditions
- StrokeBrain InjuriesAphasia
- Interventions
- Behavioral: Computer-based behavioural word reading therapyOther: Real tDCSOther: Sham tDCS
- First Posted Date
- 2014-02-13
- Last Posted Date
- 2016-11-04
- Lead Sponsor
- University College, London
- Target Recruit Count
- 23
- Registration Number
- NCT02062619
- Locations
- π¬π§
Institute of Neurology, University College London, London, United Kingdom
Zibotentan Better Renal Scleroderma Outcome Study
Phase 2
Completed
- Conditions
- Chronic Kidney DiseaseSclerodermaScleroderma Renal Crisis
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- University College, London
- Target Recruit Count
- 27
- Registration Number
- NCT02047708
- Locations
- π¬π§
Royal Free London NHS Foundation Trust, London, United Kingdom
Cannabidiol: a Novel Intervention for Cannabis Use Problems?
- First Posted Date
- 2014-01-24
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- University College, London
- Target Recruit Count
- 82
- Registration Number
- NCT02044809
- Locations
- π¬π§
Clinical Psychopharmacology Unit, London, United Kingdom
Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?
Phase 2
Terminated
- Conditions
- OsteosarcomaSpindle Cell Sarcoma of Bone
- Interventions
- First Posted Date
- 2013-12-27
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- University College, London
- Target Recruit Count
- 34
- Registration Number
- NCT02022358
- Locations
- π¬π§
University College Hospital, London, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath